Serum sex hormones and the 20-year risk of lower urinary tract symptoms in community-dwelling older men

BJU International

Volumn 105, Issue 11, 2010, Pages 1554-1559

  Trifiro, Michael D ^a   Parsons, J Kellogg ^a,b,c   Palazzi Churas, Kerrin ^a   Bergstrom, Jaclyn ^d   Lakin, Charles ^a,c   Barrett Connor, Elizabeth ^d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UCSD MEDICAL CENTER   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Benign prostatic hyperplasia; Hormones; Hypogonadism; Lower urinary tract symptoms; Testosterone

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; SEX HORMONE; STEROID HORMONE; TESTOSTERONE;

ARTICLE; COMMUNITY LIVING; HORMONE BLOOD LEVEL; HUMAN; LOWER URINARY TRACT SYMPTOM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RISK FACTOR; STEROID RELEASE;

CALIFORNIA; DIHYDROTESTOSTERONE; EPIDEMIOLOGIC METHODS; HUMANS; HYPOGONADISM; INDEPENDENT LIVING; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATISM; TESTOSTERONE;

EID: 77952192447     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.09090.x     Document Type: Article

References (29)

1. Kupelian V, Wei JT, O'Leary MP et al. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch Intern Med 2006 166 : 2381 2387 (Pubitemid 44833365)
2. Parsons JK, Bergstrom J, Silberstein J, Barett-Connor E. Prevalence and characteristics of lower urinary tract symptoms in men aged > or = 80 years. Urology 2008 72 : 318 321
3. Engstrom G, Henningsohn L, Walker-Engstrom ML, Leppert J. Impact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaire. Scand J Urol Nephrol 2006 40 : 485 494 (Pubitemid 44847030)
4. Parsons JK, Mougey J, Lambert L et al. Lower urinary tract symptoms increase the risk of falls in older men. BJU Int 2009 104 : 63 8
5. Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol 2005 173 : 1309 1313 (Pubitemid 40380559)
6. Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol 2005 173 : 1256 1261 (Pubitemid 40380548)
7. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR Baltimore Longitudinal Study of Aging. Longitudinal effects of aging on serum total and free testosterone levels in healthy men: Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001 86 : 724 731
8. Kristal AR, Schenk JM, Song Y et al. Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 2008 168 : 1416 1424
9. Miwa Y, Kaneda T, Yokoyama O. Association between lower urinary tract symptoms and serum levels of sex hormones in men. Urology 2008 72 : 552 555
10. Liu CC, Wang CJ, Huang SP, Chou YH, Wu WJ, Huang CH. Relationships between American Urological Association Symptom Index, prostate volume, and disease-specific quality of life question in patients with benign prostatic hyperplasia. Kaohsiung J Med Sci 2004 20 : 273 278
11. Rohrmann S, Nelson WG, Rifai N et al. Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III). Urology 2007 69 : 708 713 (Pubitemid 46574931) (Pubitemid 46574931) (Pubitemid 46574931)
12. Roberts RO, Jacobson DJ, Rhodes T, Klee GG, Leiber MM, Jacobsen SJ. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 2004 61 : 124 131 (Pubitemid 39244699)
13. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 2001 54 : 935 944 (Pubitemid 32771319)
14. Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, Stampfer MJ. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995 26 : 40 9
15. Tan MO, Karabiyik I, Uygur MC, Diker Y, Erol D. Serum concentrations of sex hormones in men with severe lower urinary tract symptoms and benign prostatic hyperplasia. Int Urol Nephrol 2003 35 : 357 363 (Pubitemid 39127551)
16. Schatzl G, Brossner C, Schmid S et al. Endocrine status in elderly men with lower urinary tract symptoms: correlation of age, hormonal status, and lower urinary tract function. The Prostate Study Group of the Austrian Society of Urology. Urology 2000 55 : 397 402
17. Platz EA, Kawachi I, Rimm EB et al. Plasma steroid hormones, surgery for benign prostatic hyperplasia, and severe lower urinary tract symptoms. Prostate Cancer Prostatic Dis 1999 2 : 285 289 (Pubitemid 30252207)
18. Litman HJ, Bhasin S, O'Leary MP, Link CL, McKinlay JB BACH Survey Investigators. An investigation of the relationship between sex-steroid levels and urological symptoms: results from the Boston Area Community Health survey. BJU Int 2007 100 : 321 326 (Pubitemid 47036575)
19. Barry MJ, Fowler FJ Jr., O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK. Correlation of the American Urological Association Symptom Index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association. J Urol 1992 148 : 1558 1564
20. Tremblay RR, Dube JY. Plasma concentrations of free and non-TeBG bound testosterone in women on oral contraceptives. Contraception 1974 10 : 599 605
21. Liu CC, Huang SP, Li WM et al. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men. Urology 2007 70 : 677 680
22. McConnell JD, Wilson JD, George FW, Geller J, Pappas F, Stoner E. Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab 1992 74 : 505 508
23. Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR. Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan. J Androl 2003 24 : 299 311 (Pubitemid 39571784)
24. Laughlin GA, Barrett-Connor E, Bergstrom J. Low serum testosterone and mortality in older men. J Clin Endocrinol Metab 2008 93 : 68 75
25. Karazindiyanoglu S, Cayan S. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism. Aging Male 2008 11 : 146 149
26. Kalinchenko S, Vishnevskiy EL, Koval AN, Mskhalaya GJ, Saad F. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study. Aging Male 2008 11 : 57 61 (Pubitemid 351878773)
27. Pradidarcheep W. Lower urinary tract symptoms and its potential relation with late-onset hypogonadism. Aging Male 2008 11 : 51 5 (Pubitemid 351878775)
28. Hall R, Andrews PL, Hoyle CH. Effects of testosterone on neuromuscular transmission in rat isolated urinary bladder. Eur J Pharmacol 2002 449 : 301 309
29. Smet PJ, Jonavicius J, Marshall VR, de Vente J. Distribution of nitric oxide synthase-immunoreactive nerves and identification of the cellular targets of nitric oxide in guinea-pig and human urinary bladder by cGMP immunohistochemistry. Neuroscience 1996 71 : 337 348 (Pubitemid 26067004)